Yoda Pharmaceuticals Inc.

Yoda Pharmaceuticals Inc. is a biotechnology company specializing in the research, development, and commercialization of pharmaceutical drugs specifically targeting neuropsychological and neurological diseases. Established in 2019 and headquartered in Taipei, Taiwan, the company leverages advanced artificial intelligence technology to accelerate drug discovery, aiming to introduce innovative therapies for debilitating conditions such as Alzheimer's disease, stroke, schizophrenia, brain injuries, and various endocrine and metabolic disorders. Its research portfolio emphasizes small molecule and chemical drugs, with several candidates in preclinical and early clinical phases. Yoda Pharmaceuticals is noted for its commitment to developing orphan drugs for rare neurodegenerative disorders and has reached key milestones, including initiating clinical trials for promising compounds. The company’s operations serve a vital role in the pharmaceutical sector by addressing unmet medical needs and contributing to advancements in treatments that aim to improve the quality of life for patients with complex central nervous system conditions.